Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Hangzhou Cancer Hospital"
Count: 20
Selected: 0
NCT IDTitle
NCT04481100CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
NCT03187314Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
NCT03081715PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer
NCT03554889Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
NCT02545751SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
NCT03200691Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma
NCT02544737Apatinib for Metastatic Esophageal Cancer.
NCT02745561Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.
NCT02738983RT Plus EGFR-TKI for Wild-type NSCLC
NCT02607982CCRT for Esophageal Cancer.
NCT04636593A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC
NCT02385136Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
NCT03639896Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery
NCT03374293Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer
NCT03011255Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer
NCT05028439RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
NCT02597868A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
NCT04517214Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT01918241Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia